Table 1 Summary of studies on MCA aneurysms
From: Treatment of middle cerebral artery (MCA) aneurysms: a review of the literature
Study name | Study period | Number of patients | Mean/median age | SAH | MCA aneurysm size | Follow-up (months) | Good outcome | Occlusion rate (%) | Recurrence rate (%) |
|---|---|---|---|---|---|---|---|---|---|
Surgical series | |||||||||
Suzuki et al. [23] | 1961–1981 | 413 | – | 259 (97.7 %)a | – | 0b | 85.0 % | – | – |
Rinne et al. [16] | 1977–1992 | 561 | 48.9 | 513 (91.4 %)c | 2–7 mm: 141 | 12 | 62 % (GOS ≤2) | – | – |
8–14 mm: 104 | |||||||||
15–24 mm: 38 | |||||||||
≥25 mm: 17 | |||||||||
Ogilvy et al. [32] | 1985–1989 | 62 | – | – | – | 1 | 82.3 % | – | – |
Morgan et al. [34] | 1989–2009 | 263 | 52.7 | 0 (0.0 %) | <7 mm: 153 | 1.5 | 94.7 % (mRS ≤1) | – | – |
7–14 mm: 81 | |||||||||
15–24 mm: 26 | |||||||||
≥25 mm: 20 | |||||||||
Rodriguez-Hernandez et al. [15] | 1997–2010 | 543 | 55.3 | 282 (51.9 %) | “Giant”: 30 | 46.8d | SAH: 92.0 % | 98.3 | 3.8 |
UR: 72.0 % (mRS ≤2) | |||||||||
Van Dijk et al. [1] | 2001–2006 | 105 | 52.3 | 77 (73.3 %) | <6 mm: 37 | 56.4 | 80 % (mRS ≤2) | 89 | – |
6–10 mm: 54 | |||||||||
>10 mm: 25 | |||||||||
Choi et al. [47] | 2007–2010 | 125 | 58 | 0 (0.0 %) | <5 mm: 89 | 22.5 | 100.0 % | 95.8 | 0 |
5–10 mm: 54 | |||||||||
Endovascular series | |||||||||
Suzuki et al. [41] | 1990–2007 | 115 | 55.1 | 48 (41.7 %) | <10 mm: 81 | 15.5 | 82.6 % (mRS ≤2) | 46.0 | 10.0 |
11–25 mm: 22 | |||||||||
>25 mm: 12 | |||||||||
Bracard et al. [37] | 1992–2001 | 140 | – | 73 (48.0 %)e | <4 mm: 37 | 51.6 | 89.3 % (GOS ≤2) | 84.2 | 9.1 |
4–10 mm: 90 | |||||||||
11–20 mm: 12 | |||||||||
>20 mm: 13 | |||||||||
Mortimer et al. [49] | 1996–2012 | 295 | 53.7 | 242 (82.0 %) | <10 mm: 232 | 35 | 87.1 % (GOS ≤3) | 69.4 | 30.5 |
11–24 mm: 64 | |||||||||
≥25 mm: 4 | |||||||||
Kadkhodayan et al. [38] | 1996–2013 | 292 | 56.5 | 95 (27.5 %)f | 6.6 mm | 24 | 97.1 %g | 68.5 | 8.2 |
Iijima et al. [40] | 1998–2002 | 137 | 48 | 72 (46.8 %)h | 7 mm | 15 | 89.8 % (mRS ≤3) | 77.2 | 20.0 |
Vendrell et al. [48] | 1999–2006 | 153 | 49.5 | 98 (64.1 %) | <7 mm: 104 | 50 | 92.9 % (GOS ≤2) | 64.0 | 27.2 |
7–12 mm: 59 | |||||||||
13–24 mm: 11 | |||||||||
≥25 mm: 0 | |||||||||
Doerfler et al. [50] | 2001–2005 | 31 | 48.3 | 15 (48.4 %) | <6 mm: 24 | 6 | 82.4 % | 86.8 | 20.0 |
6–10 mm: 7 | |||||||||
>10 mm: 7 | |||||||||
Brinjiki et al. [36] | 2002–2009 | 36 | 60 | 6 (16.7 %) | – | ≥3 | – | 42.9 | – |
Surgical and endovascular series | |||||||||
Regli et al. [42] | 1993–1997 | 30 | 45.2 | 0 (0.0 %) | <6 mm: 18 | 0 | – | E: 15 | – |
6–10 mm: 11 | |||||||||
11–25 mm: 4 | S: 100 | ||||||||
>25 mm: 1 | |||||||||
Güresir et al. [35] | 1999–2009 | E: 59 | E: – | E: 38 (64.4 %) | E: 7 mm | 60 | E: 69.5 % | E: 65 | E: 6.8 |
S: 271 | S: 50.4 | S: 163 (60.1 %) | S: 7 mm | S: 71.2 % | S: 98 | S: 0 | |||
Taha et al. [39] | 2001–2004 | 133 | 60.28 | 53 (39.8 %) | 7.21 mm | 26.7 | SAH: E: 62 %, S: 44 % | E: 57.5 | – |
UR: E: 93 %, S: 81 % | S: 81.4 | ||||||||
Diaz et al. [30] | 2005–2010 | E: 50 | E: 57.7 | E: 10 (20.0 %) | E: 7.12 mm | 9.02 | E: 90.0 % | E: 86 | E: 14 |
S: 34 | S: 57.7 | S: 9 (26.5 %) | S: 6.0 mm | S: 94.1 % | S: 95 | S: 0 | |||
Kim et al. [4] | 2008–2011 | E: 30 | E: 56.7 | E: 3 (10.0 %) | – | 0.25–6 | E: 86.7 % | E: 93 | – |
S: 78 | S: 58.5 | S: 9 (11.5 %) | S: 93.5 % | S: 92 | |||||